Anti-TNFR2 antibodies (Crown Bioscience)

N/A

Report date: 2025/02/08 14:47:01

Base Information

Drug NameAnti-TNFR2 antibodies (Crown Bioscience)
Drug Alias Nameantibody HuGEMM (Crown Bioscience)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionTumor necrosis factor receptor superfamily member 1B antagonists
TargetsTumor necrosis factor receptor superfamily member 1B
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCrown Bioscience Inc
China Registration ClassN/A

Develop Information

Active CompaniesCrown Bioscience Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A